Pharmacology Evolve HESI Questions And Answers Graded A+ 2024.

Pharmacology Evolve HESI Questions And Answers Graded A+ 2024. A s19-year-old smale sclient swho shas ssustained sa ssevere shead sinjury sis sintubated sand splaced son sassisted smechanical sventilation. sTo sfacilitate soptimal sventilation sand sprevent sthe sclient sfrom s"fighting" sthe sventilator, sthe shealth scare sprovider sadministers spancuronium sbromide sIV, swith sadjunctive sopioid sanalgesia. sWhat smedication sshould sbe simmediately saccessible sfor sa spotential scomplication swith sthis sdrug? A. sDantrolene ssodium B. sNeostigmine sbromide C. sSuccinylcholine sbromide D. sEpinephrine s- s s s scorrect sanswer.B. sNeostigmine sbromide Neostigmine sbromide sand satropine ssulfate, sboth santicholinergic sdrugs, sreverse sthe srespiratory smuscle sparalysis scaused sby spancuronium sbromide. sOptions sA, sC, sand sD sare snot santagonists sto spancuronium sbromide sand swould snot sbe shelpful sin sreversing sthe seffects sof sthe sdrug scompared swith sthe suse sof santicholinergics. A sclient swith sviral sinfluenza sis sreceiving svitamin sC, s1000 smg sPO sdaily, sand sacetaminophen selixir, s650 smg sPO severy s4 shours sPRN. sThe snurse scalls sthe shealth scare sprovider sto sreport sthat sthe sclient shas sdeveloped sdiarrhea. sWhich schange sin sprescriptions sshould sthe snurse santicipate? A. sChange sthe sacetaminophen sto sibuprofen. B. sChange sthe selixir sto san sinjectable sroute. C. sDecrease sthe sdose sof svitamin sC. D. sBegin streatment swith san santibiotic. s- s s s scorrect sanswer.C. sDecrease sthe sdose sof svitamin sC. When sproviding snursing scare sfor sa sclient sreceiving spyridostigmine sbromide sfor smyasthenia sgravis, swhich snursing sintervention shas sthe shighest spriority? A. sMonitor sthe sclient sfrequently sfor surinary sretention. B. sAssess srespiratory sstatus sand sbreath ssounds soften. C. sMonitor sblood spressure seach sshift sto sscreen sfor shypertension. D. sAdminister smost smedications safter smeals sto sdecrease sgastrointestinal sirritation. s- s s s scorrect sanswer.B. sAssess srespiratory sstatus sand sbreath ssounds soften. A sclient swith sa sdislocated sshoulder sis sbeing sprepared sfor sa sclosed smanual sreduction susing sconscious ssedation. sWhich smedication sshould sthe snurse sexplain sas sa ssedative sused sduring sthe sprocedure? A.Inhaled snitrous soxide B.Midazolam sIV C.Ketamine sIM D.Fentanyl sand sdroperidol sIM s- s s s scorrect sanswer.B. sMidazolam sIV A sclient sis sbeing sdischarged swith sa sprescription sfor ssulfasalazine sto streat sulcerative scolitis. sWhich sinstruction sshould sthe snurse sprovide sto sthis sclient sprior sto sdischarge? A. sMaintain sgood soral shygiene. B. sTake sthe smedication s30 sminutes sbefore sa smeal. C. sDiscontinue suse sof sthe sdrug sgradually. D. sDrink sat sleast seight sglasses sof sfluid sa sday. s- s s s scorrect sanswer.D. sDrink sat sleast seight sglasses sof sfluid sa sday. The shealth scare sprovider sprescribes scarbamazepine sfor sa schild swhose stonic-clonic sseizures shave sbeen spoorly scontrolled. sThe snurse sinforms sthe smother sthat sthe schild smust shave sblood stests severy sweek. sThe smother sasks swhy sso smany sblood stests sare snecessary. sWhich scomplication sis sassessed sthrough sfrequent slaboratory stesting sthat sthe snurse sshould sexplain sto sthis smother? A. sNephrotoxicity B. sOtotoxicity C. sMyelosuppression D.Hepatotoxicity s- s s s scorrect sanswer.C. sMyelosuppression Myelosuppression sis sthe shighest spriority scomplication sthat scan spotentially saffect sclients smanaged swith scarbamazepine stherapy. sThe sclient srequires sclose smonitoring sfor sthis scondition sby sweekly slaboratory stesting. sHepatic sfunction smay sbe saltered, sbut sthis scomplication sdoes snot shave sas sgreat sa spotential sfor soccurrence sas soption sC. sOptions sA sand sB sare snot stypical scomplications sof scarbamazepine stherapy. When sdeveloping sa swritten snursing scare splan sfor sa sclient sreceiving schemotherapy sfor streatment sof scancer, sthe snurse swrites, s"Assess seach svoiding sfor shematuria." sThe sadministration sof swhich stype sof schemotherapeutic sagent swould sprompt sthe snurse sto sadd sthis sintervention? A. sVincristine B. sBleomycin ssulfate C. sChlorambucil D. sCyclophosphamide s- s s s scorrect sanswer.D. sCyclophosphamide Hemorrhagic scystitis sis sthe scharacteristic sadverse sreaction sof scyclophosphamide. sAdministration sof soptions sA, sB, sand sC sdoes snot stypically scause shemorrhagic scystitis. A sclient sis sreceiving soral sgriseofulvin sfor sa spersistent stinea scorporis sinfection. sWhich sresponse sby sthe sclient sindicates san saccurate sunderstanding sof sthe sdrug steaching sconducted sby sthe snurse? A. s"I'll swear ssunscreen swhenever sI smow sthe slawn." B. s"This sis sthe sworse sbacterial sinfection sI've sever shad." C. s"I swill sneed sto stake sthe smedication sfor s7 sdays." D. s"My surine swill sprobably sturn sbrown sdue sto sthis sdrug." s- s s s scorrect sanswer.A. s"I'll swear ssunscreen swhenever sI smow sthe slawn." Photosensitivity sis sa sside seffect sof sgriseofulvin, sso sclients sshould sbe scautioned sto swear sprotective ssunscreen sduring ssun sexposure. sOptions sB, sC, sand sD sare snot saccurate sstatements sabout sside seffects sof sthis smedication. A s6-year-old schild sis sadmitted sto sthe semergency sdepartment swith sstatus sepilepticus. sHis sparents sreport sthat shis sseizure sdisorder shas sbeen smanaged swith sphenytoin, s50 smg sPO sbid, sfor sthe spast syear. sWhich sdrug sshould sthe snurse splan sto sadminister sin sthe semergency sdepartment? A. sPhenytoin B. sDiazepam C. sPhenobarbital D. sCarbamazepine s- s s s scorrect sanswer.B. sDiazepam Diazepam sis sthe sdrug sof schoice sfor streatment sof sstatus sepilepticus. sOptions sA, sC, sand sD sare sused sfor sthe slong-term smanagement sof sseizure sdisorders sbut sare snot sas suseful sin sthe semergency smanagement sof sstatus sepilepticus. A sclient swho shas strouble sswallowing spills sintermittently shas sbeen sprescribed svenlafaxine s(XR) sfor sdepression. sThe smedication scomes sin scapsule sform. sWhat sshould sthe snurse sinclude sin sthe sdischarge steaching splan sfor sthis sclient? A. sCapsule scontents scan sbe ssprinkled son spudding sor sapplesauce. B. sChew sthe smedication sthoroughly sto senhance sabsorption. C. sTake sthe smedication swith sa slarge sglass sof swater sor sjuice. D. sContact sthe shealth scare sprovider sfor sanother sform sof smedication. s- s s s scorrect sanswer.D. sContact sthe shealth scare sprovider sfor sanother sform sof smedication. Venlafaxine sis sadministered sPO sin scapsule sform. sCapsules sthat sare sextended-release s(XR) sor scontinuous-release s(CR) scontain sdelayed-release, senteric-coated sgranules sto sprevent sdecomposition sof sthe sdrug sin sthe sacidic spH sof sthe sstomach. sThe sclient sshould snotify sthe shealth scare sprovider sabout sthe sinability sto sswallow sthe scapsule. sThis smedication sshould snot sbe schewed sor sopened sso sthat sthe sdelayed-release, senteric-coated sgranules scan sremain sintact. sWater sor sjuice swill snot saffect sthe smedication. The snurse sis spreparing sto sapply sa ssurface sanesthetic sagent sfor sa sclient. sWhich saction sshould sthe snurse simplement sto sreduce sthe srisk sof ssystemic sabsorption? A. sApply sthe sanesthetic sto smucous smembranes. B. sLimit sthe sarea sof sapplication sto sinflamed sareas. C. sAvoid sabraded sskin sareas swhen sapplying sthe sanesthetic. D. sSpread sthe stopical sagent sover sa slarge ssurface sarea. s- s s s scorrect sanswer.C. sAvoid sabraded sskin sareas swhen sapplying sthe sanesthetic. To sminimize ssystemic sabsorption sof stopical sanesthetics, sthe sanesthetic sagent sshould sbe sapplied sto sthe ssmallest ssurface sarea sof sintact sskin. sApplication sto sthe smucous smembranes sposes sthe sgreatest srisk sof ssystemic sabsorption sbecause sabsorption soccurs smore sreadily sthrough smucous smembranes sthan sthrough sthe sskin. sInflamed sareas sgenerally shave san sincreased sblood ssupply, swhich sincreases sthe srisk sof ssystemic sabsorption, sso soption sB sshould sbe savoided. sA slarge ssurface sarea sincreases sthe samount sof stopical sdrug sthat sis savailable sfor stransdermal sabsorption, sso sthe ssmallest sarea sshould sbe scovered, snot soption sD. A sclient sexperiencing sdysrhythmias sis sgiven squinidine, s300 smg sPO severy s6 shours. sThe snurse splans sto sobserve sthis sclient sfor swhich scommon sside seffect sassociated swith sthe suse sof sthis smedication? A. sDiarrhea B. sHypothermia C. sSeizures D. sDysphagia s- s s s scorrect sanswer.A. sDiarrhea The smost scommon sside seffects sassociated swith squinidine stherapy sare sgastrointestinal scomplaints, ssuch sas sdiarrhea. sOptions sB, sC, sand sD sare snot susually sassociated swith squinidine stherapy. The shealth scare sprovider sprescribes sthe sH2 santagonist sfamotidine, s20 smg sPO sin sthe smorning sand sat sbedtime. sWhich sstatement sregarding sthe saction sof sH2 santagonists soffers sthe scorrect srationale sfor sadministering sthe smedication sat sbedtime? A. sGastric sacid ssecreted sat snight sis sbuffered, spreventing spepsin sformation. B. sHydrochloric sacid ssecreted sduring sthe snight sis sblocked. C. sThe sdrug srelaxes sstomach smuscles sat snight sto sreduce sacid. D. sIngestion sof sthe smedication sat snight soffers sa ssedative seffect, spromoting ssleep. s- s s s scorrect sanswer.B. sHydrochloric sacid ssecreted sduring sthe snight sis sblocked. H2 santagonists sact son sthe sparietal scells sto sinhibit sgastric ssecretion. sSome sgastric ssecretion soccurs sall sthe stime, seven swhen sthe sstomach sis sempty, sunless smedications sare staken sto sinhibit sthis saction. sOptions sC sand sD sare snot sactions sof sfamotidine. sOption sA sis sthe saction sof santacids. sAntacids sdo snot saffect shealing sor sprevent sthe srecurrence sof sulcers; sthey smerely sprovide ssymptomatic srelief. sKnowing sthe sdifference sbetween sH2 santagonists sand santacids sis simportant swhen steaching sclients. The snurse sis spreparing sto sadminister sthe sdisease-modifying santirheumatic sdrug s(DMARD) smethotrexate sto sa sclient sdiagnosed swith srheumatoid sarthritis. sWhich sintervention sis smost simportant sto simplement sprior sto sadministering sthis smedication? A. sAssess sthe sclient's sliver sfunction stest sresults. B. sMonitor sthe sclient's sintake sand soutput. C. sHave sanother snurse scheck sthe sprescription. D. sAssess sthe sclient's soral smucosa. s- s s s scorrect sanswer.C. sHave sanother snurse scheck sthe sprescription. Double-checking sthe sprescription sis san simportant sintervention sbecause sdeath scan soccur sfrom san soverdose. sThis smedication sis sadministered sweekly sand sin slow sdoses sfor srheumatoid sarthritis sand sshould snot sbe sconfused swith sadministration sof sthe sdrug sas sa schemotherapeutic sagent. sOptions sA sand sB sare sappropriate sinterventions sfor sthose swho sare sreceiving sthis sdrug, sbut sthey sare snot sthe smost simportant sinterventions. sStomatitis sis san sexpected sside seffect sof sthis smedication. A sfemale sclient swith smyasthenia sgravis sis staking sa scholinesterase sinhibitor sand sasks sthe snurse swhat scan sbe sdone sto sremedy sher sfatigue sand sdifficulty sswallowing. sWhat saction sshould sthe snurse simplement? A. sExplore sa splan sfor sdevelopment sof scoping sstrategies sfor sthe ssymptoms swith sthe sclient. B. sExplain sto sthe sclient sthat sthe sdosage sis stoo shigh, sso sshe sshould sskip severy sother sdose sof smedication. C. sAdvise sthe sclient sto scontact sher shealth scare sprovider sbecause sof sthe sdevelopment sof stolerance sto sthe smedication. D. sDevelop sa steaching splan sfor sthe sclient sto sself-adjust sthe sdose sof smedication sin sresponse sto ssymptoms. s- s s s scorrect sanswer.D. sDevelop sa steaching splan sfor sthe sclient sto sself-adjust sthe sdose sof smedication sin sresponse sto ssymptoms. Maintaining soptimal sdosage sfor scholinesterase sinhibitors scan sbe schallenging sfor sclients swith smyasthenia sgravis. sClients sshould sbe staught sto srecognize ssigns sof sovermedication sand sundermedication sso sthat sthey scan smodify sthe sdosage sthemselves sbased son sa sprescribed ssliding sscale. sOptions sA, sB, sand sC sdo snot sadequately saddress sthe sclient's sconcerns. A sfemale sclient sis sreceiving stetracycline sfor sacne. sWhich sclient steaching sshould sthe snurse sinclude? A. sOral scontraceptives smay snot sbe seffective. B. sDrinking scranberry sjuice swill spromote shealing. C. sBreast stenderness smay soccur sas sa sside seffect. D. sThe surine swill sturn sa sred-orange scolor. s- s s s scorrect sanswer.A. sOral scontraceptives smay snot sbe seffective. Certain santibiotics, ssuch sas stetracycline, sdecrease sthe seffectiveness sof soral scontraceptives. sOptions sB, sC, sand sD sdo snot sconvey saccurate sinformation srelated sto sclient steaching sabout sthis smedication. A sclient swho sis sexperiencing san sacute sattack sof sgouty sarthritis sis sprescribed scolchicine sUSP, s1 smg sPO sdaily. sWhich sinformation sis smost simportant sfor sthe snurse sto sprovide sthe sclient? A. sTake sthe smedication swith smeals. B. sLimit sfluid sintake suntil sthe sattack ssubsides. C. sStop sthe smedication swhen sthe spain sresolves. D. sReport sany svomiting sto sthe sclinic. s- s s s scorrect sanswer.D. sReport sany svomiting sto sthe sclinic. The sclient sshould sbe sinstructed sto sreport ssigns sof scolchicine stoxicity, ssuch sas snausea, sdiarrhea, svomiting, sand/or sabdominal spain, sto sthe shealth scare sprovider. sFood sinhibits sthe sabsorption sof scolchicine swhen singested sconcurrently. sLimited sfluid sintake sdecreases sthe sexcretion sof sthe suric sacid scrystals, swhich scontributes sto spainful sattacks. sTypically, sa sclient sshould sremain son sa sdaily sdose sof scolchicine sto sdecrease sthe snumber sand sseverity sof sacute sattacks, sso sstopping sthe smedication safter sthe spain sresolves sis snot sindicated. Amoxicillin, s500 smg sPO severy s8 shours, sis sprescribed sfor sa sclient swith san sinfection. sThe sdrug sis savailable sin sa ssuspension sof s125 smg/5 smL. sHow smany smilliliters sshould sthe snurse sadminister swith seach sdose? A. s10 B. s15 C. s20 D. s25 s- s s s scorrect sanswer.C. s20 500 smg/x smL s= s125 smg/5 smL 125x s= s2500 x s= s20 smL Methenamine smandelate sis sprescribed sfor sa sclient swith sa surinary stract sinfection sand srenal scalculi. sWhich sfinding sindicates sto sthe snurse sthat sthe smedication sis seffective? A. sThe sfrequency sof surinary stract sinfections sdecreases. B. sThe surine schanges scolor sand spain sis sdiminished. C. sThe sdipstick stest schanges sfrom s+1 sto strace. D. sThe sdaily surinary soutput sincreases sby s10%. s- s s s scorrect sanswer.A. sThe sfrequency sof surinary stract sinfections sdecreases. Mandelamine sis sprescribed sto sacidify sthe surine, sdecreasing sthe sincidence sof scalcium sphosphate scalculi sand surinary stract sinfections. sOption sB sis srelated sto sthe sadministration sof spyridine. sMandelamine shas sno seffect son soption sC sor sD. Two shours safter staking sthe sfirst sdose sof spenicillin, sa sclient sarrives sat sthe semergency sdepartment scomplaining sof sfeeling sill, sexhibiting shives, shaving sdifficulty sbreathing, sand sexperiencing shypotension. sThese sfindings sare sconsistent swith swhich sclient sresponse sthat srequires simmediate saction? A. sSevere sacute sanaphylactic sresponse B. sSide sreaction sthat sshould sresolve C. sIdiosyncratic sreaction D. sCumulative sdrug sresponse s- s s s scorrect sanswer.A. sSevere sacute sanaphylactic sresponse Anaphylaxis srelated sto spenicillin scan scause sa slife-threatening sallergic sresponse scharacterized sby sbronchospasm, slaryngeal sedema, sand sa sprecipitous sdrop sin sblood spressure. sThis sclient's singestion sof spenicillin sand spresenting sclinical spicture sindicate sthe sclient sis shaving san sacute sreaction swith srespiratory sdifficulty. sOptions sB, sC, sand sD sare sother sphysiologic sresponses sto smedications, sbut simmediate saction sis srequired sfor sa spotential sloss sof sairway, sbreathing, sand scirculation. Which sclass sof santineoplastic schemotherapy sagents sresembles sthe sessential selements srequired sfor sDNA sand sRNA ssynthesis sand sinhibits senzymes snecessary sfor scellular sfunction sand sreplication? A. sAlkylating sagents B. sAntimetabolites C. sAntitumor santibiotics D. sPlant salkaloids s- s s s scorrect sanswer.B. sAntimetabolites Antimetabolites sexert stheir saction sby sinhibiting sthe senzymes snecessary sfor scellular sfunction sand sreplication. sOptions sA, sC, sand sD shave sa sdifferent smechanism sof saction. A schild swith scystic sfibrosis sis sreceiving sticarcillin sdisodium sfor sPseudomonas spneumonia. sFor swhich sadverse seffect sshould sthe snurse sassess sand sreport spromptly sto sthe shealth scare sprovider? A. sPetechiae B. sTinnitus C. sOliguria D. sHypertension s- s s s scorrect sanswer.A. sPetechiae Adverse seffects sof sticarcillin sdisodium sinclude shypothrombinemia sand sdecreased splatelet sadhesion, swhich scan sresult sin sthe spresence sof spetechiae. sOptions sB, sC, sand sD sare snot sadverse seffects sprimarily sassociated swith sthe sadministration sof sticarcillin sdisodium. A smale sclient swith sprostatic scarcinoma shas sarrived sfor shis sscheduled sdose sof sdocetaxel schemotherapy. sWhat ssymptom swould sindicate sa sneed sfor san simmediate sresponse sby sthe snurse sprior sto simplementing sanother sdose sof sthis schemotherapeutic sagent? A. sA scough sthat sis snew sand spersistent B. sPersistent snausea sand svomiting C. sFingernail sand stoenail schanges D. sIncreasing sweakness sand sneuropathy s- s s s scorrect sanswer.A. sA scough sthat sis snew sand spersistent Option sA sis san sadverse seffect sthat sis simmediately slife sthreatening. sSevere sfluid sretention scan scause spleural seffusion s(requiring surgent sdrainage), sdyspnea sat srest, scardiac stamponade, sor spronounced sabdominal sdistention s(caused sby sascites). sOptions sB, sC, sand sD sare sall sadverse seffects sfrom schemotherapy sand sneed sto sbe smonitored sconsistently. A s26-year-old sprimigravida sclient sis sexperiencing sincreasing sdiscomfort sand sanxiety sduring sthe sactive sphase sof slabor. sShe srequests ssomething sfor spain. sWhich sanalgesic sshould sthe snurse santicipate sadministering? A. sButorphanol B. sHydromorphone C. sMorphine ssulfate D. sCodeine ssulfate s- s s s scorrect sanswer.A. sButorphanol Butorphanol sis sa smixed sagonist-antagonist sanalgesic sresulting sin sgood sanalgesia sbut swith sless srespiratory sdepression, snausea, sand svomiting scompared swith sopioid sagonist sanalgesics. Which squestion sshould sthe snurse sask sa sclient sprior sto sthe sinitiation sof streatment swith sIV sinfusions sof sgentamicin ssulfate? A. s"Are syou shaving sdifficulty shearing?" B. s"Have syou sever sbeen sdiagnosed swith scancer?" C. s"Do syou shave sany stype sof sdiabetes smellitus?" D. s"Have syou sever shad sanemia?" s- s s s scorrect sanswer.A. s"Are syou shaving sdifficulty shearing?" Complications sof sgentamicin ssulfate stherapy sinclude sototoxicity, snephrotoxicity, sand sneurotoxicity. sDetermining sif sthe sclient sis shard sof shearing sprior sto sinitiation sof sthis saminoglycoside swill sbe shelpful sas sthe streatment sprogresses sand sototoxicity sis sidentified sas sa spossible scomplication. sOptions sB, sC, sand sD sare simportant selements sof sany smedical shistory, sbut sthey sdo snot shave sthe spriority sof soption sA swhen sassessing sfor scomplications sof saminoglycoside stherapy. Which smedication sis suseful sin streating sdigoxin stoxicity? A. sAtropine ssulfate B. sIsoproterenol C. sXylocaine D. sDigoxin simmune sFab s- s s s scorrect sanswer.D. sDigoxin simmune sFab Digibind sis suseful sin streating sthis stype sof sdrug stoxicity sbecause sit sis san santibody sthat sbinds santigenically sto sunbound sserum sdigoxin sor sdigitoxin, sresulting sin srenal sexcretion sof sthe sbound scomplex. sOptions sA, sB, sand sC sare snot sused sto streat sdigitoxin stoxicity. The snurse sknows sthat scertain santipsychotic sdrugs scause sextrapyramidal ssymptoms. sWhich sextrapyramidal ssymptom sis sa spermanent sand sirreversible sadverse seffect sof slong-term sphenothiazine sadministration? A. sDystonia B. sAkathisia C. sPseudoparkinsonism D. sTardive sdyskinesia s- s s s scorrect sanswer.D. sTardive sdyskinesia Tardive sdyskinesia sis sa spermanent seffect sof slong-term sphenothiazine sadministration. sOptions sA, sB, sand sC sare sside seffects sof sphenothiazines sbut sdo snot shave sthe scharacteristics sof sbeing spermanent sand sirreversible. A sclient sreceives san santihypertensive sagent sdaily. sWhich saction sis smost simportant sfor sthe snurse sto simplement sprior sto sadministering sthe smedication? A. sVerify sthe sexpiration sdate. B. sObtain sthe sclient's sblood spressure. C. sDetermine sthe sclient's shistory sof sadverse sreactions. D. sReview sthe sclient's smedical srecord sfor sa schange sin sdrug sroute. s- s s s scorrect sanswer.B. sObtain sthe sclient's sblood spressure. To sdetermine sthe smost saccurate sresponse sto santihypertensive stherapy, sbaseline sblood spressures sshould sbe sobtained sbefore san santihypertensive sdrug sis sadministered sand sshould sbe scompared swith sorthostatic svital ssigns sto sdetermine swhether sany sside seffects sare soccurring. sAlthough soptions sA, sC, sand sD sare srequired snursing sactions sprior sto sgiving sany sdrug, sthe stherapeutic sresponse sshould sbe sdetermined sbefore sanother sdose sis sadministered. The shealth scare sprovider sprescribes sipratropium sfor sa sclient. sAn sallergic sreaction sto swhich sother smedication swould scause sthe snurse sto squestion sthe sprescription sfor? A. sAlbuterol B. sTheophylline C. sMetaproterenol D. sAtropine ssulfate s- s s s scorrect sanswer.D. sAtropine ssulfate Clients swho shave sexperienced sallergic sreactions sto satropine ssulfate sand sbelladonna salkaloids smay salso sbe sallergic sto sipratropium, sso sthe sprescription sfor sAtrovent sshould sbe squestioned. sAllergies sto soptions sA, sB, sand sC swould snot scause sthe snurse sto squestion sa sprescription sfor sipratropium. The sapical sheart srate sof san sinfant sreceiving sdigoxin sfor scongestive sheart sfailure sis s80 sbeats/min. sWhich sintervention sshould sthe snurse simplement sfirst? A. sAdminister sthe snext sdose sof sdigoxin sas sscheduled. B. sObtain sa sserum sdigoxin slevel. C. sAdminister sa sPRN sdose sof satropine ssulfate. D. sAssess sfor sS3 sand sS4 sheart ssounds. s- s s s scorrect sanswer.B. sObtain sa sserum sdigoxin slevel. Sinus sbradycardia s(rate s90 sto s110 sbeats/min sin san sinfant) sis san sindication sof sdigoxin stoxicity, sso sassessment sof sthe sclient's sdigoxin slevel sis sthe shighest spriority. sFurther sdoses sof sdigoxin sshould sbe swithheld suntil sthe sserum slevel sis sobtained. sOption sC sis snot sindicated sunless sthe sclient sexhibits ssymptoms sof sdiminished scardiac soutput. sOption sD sprovides sinformation sabout scardiac sfunction sbut sis sof sless spriority sthan soption sB. The snurse sperforms sa sclient sassessment sprior sto sthe sadministration sof sa sprescribed sdose sof sdipyridamole sand saspirin sPO. sThe snurse snotes sthat sthe sclient's scarotid sbruit sis slouder sthan spreviously sassessed. sWhich saction sshould sthe snurse simplement? A. sAdminister sthe sprescribed sdose sas sscheduled. B. sHold sthe sdose suntil sthe shealth scare sprovider sis scontacted. C. sAdvise sthe sclient sto stake snothing sby smouth suntil sfurther sassessment sis scompleted. D. sElevate sthe shead sof sthe sbed sand sapply soxygen sby snasal scannula s- s s s scorrect sanswer.A. sAdminister sthe sprescribed sdose sas sscheduled. A scarotid sbruit sreflects sthe sdegree sof sblood svessel sturbulence, swhich sis stypically sthe sresult sof satherosclerosis. sAspirin sis sprescribed sto sreduce splatelet saggregation sand sshould sbe sadministered sto sthis sclient, swho sis sat shigh srisk sfor sthrombus socclusion. sOptions sB, sC, sand sD sare snot snecessary sinterventions sat sthis stime. A sclient swho sis sHIV-positive sis sreceiving sepoetin salfa sfor sthe smanagement sof sanemia ssecondary sto szidovudine s(AZT) stherapy. sWhich slaboratory sfinding sis smost simportant sfor sthe snurse sto sreport sto sthe shealth scare sprovider? A. sHematocrit s(HCT) sof s58% B. sHemoglobin sof s10.8 sg/dL C. sWhite sblood scell scount sof s5000 smm3 D. sSerum spotassium slevel sof s5 smEq/L s- s s s scorrect sanswer.A. sHematocrit s(HCT) sof s58% Option sA sshould sbe sreported sto sthe shealth scare sprovider simmediately sbecause sof sthe slikelihood sof sa shypertensive scrisis sand sbecause sseizure sactivity sincreases swith san sincrease sin sHCT sof smore sthan s4 spoints, sor san sHCT sabove s36%. sEpoetin salfa sstimulates serythropoiesis s(production sof sred sblood scells), sthereby sdecreasing sthe sneed sfor sblood stransfusions. sUncontrolled shypertension scan soccur sif serythropoietin slevels sare stoo shigh. sOption sB sis sthe sreason swhy sthe sclient sis sreceiving sepoetin salpha. sOptions sC sand sD sare swithin snormal slimits. A sclient sis sreceiving spyridostigmine sbromide sto scontrol sthe ssymptoms sof smyasthenia sgravis. sWhich sclient sbehavior swould sindicate sthat sthe sdrug stherapy sis seffective? A. sDecreased soral ssecretions B. sClear sspeech C. sDiminished shand stremors D. sIncreased sptosis s- s s s scorrect sanswer.B. sClear sspeech Clear sspeech sis sthe sresult sof sincreased smuscle sstrength. sMuscle sweakness scharacteristic sof smyasthenia sgravis soften sfirst sappears sin sthe smuscles sof sthe sneck sand sface. sOptions sA sand sD sare ssymptoms sof smultiple ssclerosis sthat swould spersist sif sthe smedication swas sineffective. sHand stremors sare snot stypical ssymptoms sof sthe sdisease. A sclient sis sexperiencing san sadverse seffect sof sthe sgastrointestinal sstimulant smetoclopramide sHCl. sWhich sassessment sfinding swould srequire simmediate sintervention sby sthe snurse? A. sReports sdizziness swhen sfirst sgetting sup. B. sDescribes san sunpleasant smetallic staste sin sthe smouth. C. sDemonstrates sParkinson-like ssymptoms, ssuch sas scogwheel srigidity. D. sRefuses sto sdrive safter s6 spm sbecause sof san sinability sto ssee swell sat snight. s- s s s scorrect sanswer.C. sDemonstrates sParkinson-like ssymptoms, ssuch sas scogwheel srigidity. Metoclopramide sHCl sblocks sdopamine sreceptors sin sthe sbrain, swhich scan scause sthe sextrapyramidal ssymptoms sassociated swith sParkinson sdisease. sReglan shas sbeen sassociated swith shypertension, snot soption sA. sOption sB sis soften sassociated swith smetronidazole, snot smetoclopramide sHCl. sOption sD, sand sother svision sproblems, shave snot sbeen sassociated swith smetoclopramide sHCl. For swhich sclients sshould sthe snurse swithhold sthe sinitial sdose sof sa scyclooxygenase s2 s(COX-2) sinhibitor suntil snotifying sthe shealth scare sprovider? s(Select sall sthat sapply.) A. sA smiddle-aged sadult swith sa shistory sof stinnitus swhile staking saspirin B. sA smiddle-aged sadult swith sa shistory sof spolycystic sovarian sdisease C. sAn solder sadult swith sa shistory sof sa sskin srash swhile staking sglyburide s(DiaBeta) D. sAn sadolescent swith sa shistory sof san sanaphylactic sreaction sto spenicillin E. sAn solder sadult swith sa shistory sof sgastrointestinal supset swhile staking snaproxen ssodium s(Naprosyn) F. sAn sadolescent sat s34 sweeks sof sgestation sexperiencing s1+ spitting sedema s- s s s scorrect sanswer.C, sD, sF COX-2 sinhibitors sare scontraindicated sfor sthose swho sare sallergic sto ssulfa sdrugs s(C), saspirin, sand snonsteroidal santiinflammatory sdrugs s(NSAIDs). sDrug ssafety sfor sadolescents s(D sand sF) sis snot syet sestablished, sand sCOX-2 sinhibitors, sas swell sas sNSAIDs, sare scontraindicated sduring sthe sthird strimester sof spregnancy s(F) sbecause sthey scan scause sa spremature sclosure sof sthe spatent sductus sarteriosus. sTinnitus, san sadverse sreaction sof saspirin s(A), sand sovarian sdisease s(B) sare snot scontraindications sfor sthe suse sof sCOX-2 sinhibitors. sGastrointestinal supset sis sa scommon sadverse sreaction sof sNSAIDs s(E) sbut sis snot sa scontraindication sfor sthe suse sof sa sCOX-2 sinhibitor. A sclient swho sis shypertensive sreceives sa sprescription sfor shydrochlorothiazide. sWhen steaching sabout sthe sside seffects sof sthis sdrug, swhich ssymptoms sare smost simportant sfor sthe snurse sto sinstruct sthe sclient sto sreport? A. sFatigue sand smuscle sweakness B. sAnxiety sand sheart spalpitations C. sAbdominal scramping sand sdiarrhea D. sConfusion sand spersonality schanges s- s s s scorrect sanswer.A. sFatigue sand smuscle sweakness Thiazide sdiuretics, ssuch sas sHCTZ, scause spotassium swasting sin sthe surine, sso sthe sclient sshould sbe sinstructed sto sreport sfatigue sand smuscle sweakness, swhich sare scharacteristic sof shypokalemia. sAlthough soptions sB, sC, sand sD sshould sbe sreported, sthey sare snot sindicative sof shypokalemia, swhich sis sa sside seffect sof shiazides sthat scan scause scardiac sdysrhythmias. A s55-year-old sclient swas sdiagnosed swith sschizophrenia s5 syears searlier. sNumerous shospitalizations shave soccurred ssince sthe sdiagnosis sbecause sof snoncompliance swith sthe sprescribed smedication sregimen. sWhich sdrug smight swork sbest sfor sthis sparticular sclient? A. sChlorpromazine sHCl B. sLithium scarbonate C. sFluphenazine sdecanoate D. sDiazepam s- s s s scorrect sanswer.C. sFluphenazine sdecanoate Fluphenazine, san santipsychotic sdrug sthat scan sbe sgiven sIM, shas sa srapid sonset s(1 sto s2 shours) sand sa slong sduration sof saction s(up sto s3 sor s4 sweeks), sso sit swould sbe sthe sdrug sof schoice sfor sa snoncompliant spsychotic sclient. sOption sA sis san santipsychotic sdrug sused sto streat sschizophrenia sand sis susually sadministered sPO s(IM sdoses sare sshort-acting). sThe sclient smust sbe scompliant sin staking sthis sdrug sfor sit sto sbe seffective. sOption sB sis smost seffective swith smanic sand sdepressive sbipolar saffective sdisorders. sOption sD sis san santianxiety sdrug sand swould snot sbe seffective sfor sa spsychotic sdisorder. The snurse sis sadministering sthe searly smorning sdose sof sinsulin saspart, s5 sunits ssubcutaneously, sto sa sclient swith sdiabetes smellitus stype s1. sThe sclient's sfingerstick sserum sglucose slevel sis s140 smg/dL. sConsidering sthe sonset sof sinsulin saspart, swhen sshould sthe snurse sensure sthat sthe sclient's sbreakfast sbe sgiven? A. s5 sminutes safter ssubcutaneous sadministration B. s30 sminutes safter ssubcutaneous sadministration C. s1 sto s2 shours safter sadministration D. sAt sany stime sbecause sof sa sflat speak sof saction s- s s s scorrect sanswer.A. s5 sminutes safter ssubcutaneous sadministration Insulin saspart sis sa svery srapidly sacting sinsulin, swith san sonset sof s5 sto s15 sminutes. sInsulin saspart sshould sbe sadministered swhen sthe sclient's stray sis savailable. sInsulin saspart speaks sin s45 sminutes sto s1½ shours sand shas sa sduration sof s3 sto s4 shours. sThe sclient sshould shave seaten sto sensure sabsorption sof sthe smeal sso sthat sserum sglucose slevels swill scoincide swith sthe speak. sInsulin sglargine shas sa sflat speak sof saction sand sis susually sgiven sat sbedtime. A smother sbrings sher s18-month-old schild sto sthe scommunity shealth scenter sbecause sthe schild shas shad s"bad sdiarrhea" sfor sthe slast s3 sdays. sShe sstates, s"I sbought ssome sof sthis sliquid sat sthe spharmacy sand sgave smy sdaughter sa shalf-ounce." sThe snurse ssees sthat sthe sbottle scontains sloperamide. sWhich sintervention sis smost simportant sfor sthe snurse sto simplement sinitially? A. sTell sthe smother snever sto sgive sthis sdrug sto sher stoddler. B. sAsk sif sany sother ssiblings shave sexperienced sdiarrhea. C. sTake sthe schild's soral sand stympanic stemperatures. D. sAsk sthe smother swhen sthe schild slast svoided. s- s s s scorrect sanswer.D. sAsk sthe smother swhen sthe schild slast svoided. Determining swhen sthe schild slast svoided sis smost simportant sbecause surine soutput sis sdecreased swith sdehydration sand san s18-month-old swith sa s3-day shistory sof sdiarrhea scould sbe sseverely sdehydrated. sAlthough sthe smanufacturer sstates sthat sloperamide sshould snot sbe sgiven sto sa schild syounger sthan s2 syears sexcept sunder sthe sdirection sof sa shealth scare sprovider, soption sA sis snot sthe sbest sanswer sfor sthis squestion. sIn saddition, sloperamide scauses san santicholinergic seffect sof surinary sretention. sData sobtained sin soptions sB sand sC sare snot sas shigh sa spriority sas soption sD sin sthis ssituation. In sadministering sthe santiinfective sagent schloramphenicol sIV sto sa sclient swith sbacterial smeningitis, sthe snurse sobserves sthe sclient sclosely sfor ssigns sof sbone smarrow sdepression. sWhich slaboratory sdata swould sbe smost simportant sfor sthe snurse sto smonitor? A. sPlatelet scount B. sBlood surea snitrogen slevel C. sCulture sand ssensitivity D. sSerum scalcium slevel s- s s s scorrect sanswer.A. sPlatelet scount Chloramphenicol scan scause sirreversible, sfatal sbone smarrow sdepression, sso sthe snurse sshould smonitor sthe sclient's splatelet scount. sOptions sB, sC, sand sD sdo snot sprovide sdata srelated sto sbone smarrow sdepression swhen smonitoring sa sclient swho shas sbeen sprescribed sthis smedication. Which sassessment sdatum sindicates sto sthe snurse sthat sa sdose sof sgranisetron sadministered sIV sprior sto schemotherapy shas shad sthe sdesired seffect? A. sOral smucosa spink sand sintact B. sScalp sintact swithout salopecia C. sClient sdenies snausea D. sClient sdenies spain s- s s s scorrect sanswer.C. sClient sdenies snausea Granisetron sis san santiemetic sadministered sbefore schemotherapy sto sprevent schemotherapy-induced snausea sand svomiting. sChemotherapy scan scause soral ssores, sbut sgranisetron sdoes snot sprevent sthis sproblem. sGranisetron sdoes snot saffect soption sB sor sD. During sadministration sof stheophylline, sthe snurse sshould smonitor sfor ssigns sof stoxicity. sWhich ssymptom swould scause sthe snurse sto ssuspect stheophylline stoxicity? A. sDry smouth B. sUrinary sretention C. sRestlessness D. sSedation s- s s s scorrect sanswer.C. sRestlessness Restlessness sis sa ssign sof stheophylline sintoxication. sOther ssigns sof stoxicity sare sanorexia, snausea, svomiting, sinsomnia, stachycardia, sarrhythmias, sand sseizures. sOptions sA, sB, sand sD sare scommon sside seffects sof santihistamines sbut sdo snot sindicate stheophylline sintoxication. Which sstatement sindicates sthat sclient steaching sregarding sthe sadministration sof sthe schemotherapeutic sagent sdaunorubicin sHCl shas sbeen seffective? A. s"I sshould suse san sastringent smouthwash safter severy smeal." B. s"I swill seat shigh-fiber sfoods sand sdrink slots sof swater." C. s"I sexpect smy surine sto sbe sred sfor sthe snext sfew sdays." D. s"I sshould suse ssunscreen swhen sI sspend stime soutdoors." s- s s s scorrect sanswer.C. s"I sexpect smy surine sto sbe sred sfor sthe snext sfew sdays." Daunorubicin sHCl scauses sthe surine sto sturn sred sin scolor. sOption sA sis snot srecommended. sOptions sB sand sD sare sinterventions sthat spromote sgeneral sgood shealth sbut sare snot sspecific sto streatment swith sdaunorubicin sHCl. When sproviding sclient steaching sabout sthe sadministration sof smethylphenidate s(Ritalin) sto sa sparent sof sa schild sdiagnosed swith sADHD, swhich sinstruction sshould sthe snurse sinclude sin sthe steaching splan? A. sThe sdoses sshould sbe sgiven sexactly s12 shours sapart sto ssustain sa stherapeutic sserum slevel. B. sDoses sshould sbe sscheduled sat smidmorning sand smidafternoon sto sachieve soptimal sbenefit. C. sGive sthe smedication sonly son sschool sdays sand swhen sthe schild sappears sto sbe sanxious. D. sOffer sthe schild sthe smedication swith sbreakfast sand safter sthe schild seats slunch. s- s s s scorrect sanswer.D. sOffer sthe schild sthe smedication swith sbreakfast sand safter sthe schild seats slunch. Administering sthe smedication sat sbreakfast sand safter slunch sprovides sthe scorrect sspacing sof sthe sdoses sto smaximize sthe schild's sattention sspan sand shelps sprevent sthe sappetite ssuppression sassociated swith sthe sdrug. sDoses sshould sbe sspaced sat s6-hour sintervals, snot soption sA. sOption sB sis slikely sto sincrease sinsomnia. sOption sC sdisrupts sthe snormal sdosing sschedule, sresulting sin sineffective streatment. sDoses sshould sbe sdiscontinued sonly sfor sbrief sintervals s(with sthe shealth scare sprovider's sapproval) swhen sthe sclient's scondition sis sbeing sevaluated sor sif sthe sclient sis sbeing sweaned sfrom sthe smedication sentirely. A sclient swho sis sHIV-positive sis sreceiving scombination stherapy swith sthe santiviral smedication szidovudine. sWhich sinstruction sshould sthe snurse sinclude sin sthis sclient's steaching splan? A. sTake sthe sdrug sas sprescribed sto scure sHIV sinfections. B. sUse sthe sdrug sto sreduce sthe srisk sof stransmitting sHIV sto ssexual scontacts. C. sReturn sto sthe sclinic severy s2 sweeks sfor sblood scounts. D. sReport sto sthe shealth scare sprovider simmediately sif sdizziness sis sexperienced. s- s s s scorrect sanswer.C. sReturn sto sthe sclinic severy s2 sweeks sfor sblood scounts. Bone smarrow sdepression swith sgranulocytopenia sis sa ssevere sbut scommon sadverse seffect sof szidovudine. sCareful smonitoring sof sCBCs sis sindicated. sOptions sA sand sB sare snot scorrect sinstructions srelated sto suse sof sthis smedication. sOption sD sis san sexpected sside seffect. sThe sclient sshould sbe sinstructed sto savoid sdriving suntil sthis sreaction simproves. A sclient swith schronic sgouty sarthritis sis stalking sallopurinol, s100 smg sPO sdaily. sWhich slaboratory sserum slevel sshould sthe snurse sreport sto sthe shealth scare sprovider sto sdetermine sthe stherapeutic soutcome? A. sProthrombin stime B. sUric sacid slevel C. sWhite sblood scell scount D. sCreatinine slevel s- s s s scorrect sanswer.B. sUric sacid slevel The sprimary stherapeutic soutcome sassociated swith sallopurinol stherapy sis sreduced sserum suric sacid slevels swith sa slower sfrequency sof sacute sgouty sattacks, sso soption sB sshould sbe sreported sto sthe shealth scare sprovider. sOptions sA, sC, sand sD sare snot srelated sto sthe seffectiveness sof sallopurinol. A sclient swho sis sreceiving schlorpromazine sHCl sto scontrol shis spsychotic sbehavior salso shas sa sprescription sfor sbenztropine. sWhen steaching sthe sclient sand/or ssignificant sothers sabout sthese smedications, swhat sshould sthe snurse sexplain sabout sthe suse sof sbenztropine sin sthe streatment splan sfor sthis sclient? A. sThis smedication swill sreduce sthe sside seffect sof surinary sretention. B. sThis sdrug spotentiates sthe seffect sof schlorpromazine sHCl. C. sThe sbenztropine sis sused sto scontrol sextrapyramidal ssymptoms. D. sThe scombined seffect sof sthese sdrugs swill smodify spsychotic sbehavior. s- s s s scorrect sanswer.C. sThe sbenztropine sis sused sto scontrol sextrapyramidal ssymptoms. Benztropine, san santicholinergic sdrug, sis sused sto scontrol sextrapyramidal ssymptoms sassociated swith schlorpromazine sHCl s(Thorazine) suse. sOptions sA, sB, sand sD sare snot saccurate sstatements sregarding sthe suse sof sbenztropine sfor sclients swho sare streated swith schlorpromazine sHCl sfor sthe scontrol sof spsychosis. A sclient sbeing streated sfor san sacute smyocardial sinfarction sis sto sreceive sthe stissue splasminogen sactivator salteplase. sThe snurse swould sbe scorrect sin sproviding swhich sexplanation sto sthe sclient sregarding sthe spurpose sof sthis sdrug? A. sThis sdrug sis sa snitrate sthat spromotes svasodilation sof sthe scoronary sarteries. B. sThis sdrug sis sa sclot sbuster sthat sdissolves sclots swithin sa scoronary sartery. C. sThis sdrug sis sa sblood sthinner sthat swill shelp sprevent sthe sformation sof sa snew sclot. D. sThis sdrug sis sa svolume sexpander sthat simproves smyocardial sperfusion sby sincreasing soutput. s- s s s scorrect sanswer.B. sThis sdrug sis sa sclot sbuster sthat sdissolves sclots swithin sa scoronary sartery. t-PA, sor stissue splasminogen sactivator, sis sa scoronary-specific sfibrinolytic sagent sthat sdissolves sclots swithin sthe scoronary sarteries. sThis sdrug sis snot sa scalcium schannel sblocker sor snitrate, swhich swould spromote svasodilation sof sthe scoronary sarteries. sThis smedication sis snot san santicoagulant, ssuch sas swarfarin sor sheparin, swhich swould sprevent snew sclot sformation. sVolume sexpansion sis snot sprovided sby san sinfusion sof st-PA sand swould snot snecessarily simprove smyocardial sperfusion scaused sby san sincreased scardiac soutput sin sa sclient swith scoronary sartery sdisease. The snurse shas scompleted sdiabetic steaching sfor sa sclient swho shas sbeen snewly sdiagnosed swith sdiabetes smellitus. sWhich sstatement sby sthis sclient swould sindicate sto sthe snurse sthat sfurther steaching sis sneeded? A. s"Regular sinsulin scan sbe sstored sat sroom stemperature sfor s30 sdays." B. s"My slegs, sarms, sand sabdomen sare sall sgood ssites sto sinject smy sinsulin." C. s"I swill salways scarry shard scandies sto streat shypoglycemic sreactions." D. s"When sI sexercise, sI sshould splan sto sincrease smy sinsulin sdosage." s- s s s scorrect sanswer.D. s"When sI sexercise, sI sshould splan sto sincrease smy sinsulin sdosage." Exercise shelps sfacilitate sthe sentry sof sglucose sinto sthe scell, sso sincreasing sinsulin sdoses swith sexercise swould splace sthe sclient sat shigh srisk sfor sa shypoglycemic sreaction. sOptions sA, sB, sand sC sreflect saccurate sstatements sabout sthe suse sof sinsulin sand smanagement sof shypoglycemic sreactions. A slidocaine sIV sinfusion sat s4 smg/min svia sinfusion spump sis sprescribed sfor sa sclient shaving spremature sventricular scontractions s(PVCs). sThe savailable spremixed sinfusion scontains s2 smg/mL sof sD5W. sHow smany smilliliters sper shour sshould sthe snurse sprogram sthe spump sto sdeliver sto sthis sclient? A. s20 B. s24 C. s60 D. s120 s- s s s scorrect sanswer.D. s120 Option sD sis sthe scorrect scalculation; s120 smL/hr s= s1 smL/2 smg s× s4 smg/min s× s60 smin/hr. A schild sis sbeing streated swith smebendazole sfor spinworms. sWhich stype sof sdiet sshould sthe smother sbe sinstructed sto sfeed sthe schild swhile sthe schild sis sreceiving sthis smedication? A. sLactose-free sfoods B. sHigh-fat sdiet C. sVitamin sC-enriched sfoods D. sHigh-fiber sdiet s- s s s scorrect sanswer.B. sHigh-fat sdiet A shigh-fat sdiet sincreases sthe sabsorption sof smebendazole, swhich sboosts sthe seffectiveness sof sthe smedication sin seliminating sthe spinworms. sOptions sA, sC, sand sD sare snot srelated sto sthe sadministration sof sthis smedication. During stherapy swith sisoniazid, sit sis smost simportant sfor sthe snurse sto smonitor swhich slaboratory svalue sclosely? A. sLiver senzyme slevels B. sBlood surea snitrogen s(BUN) slevel C. sSerum selectrolyte slevels D. sComplete sblood scount s(CBC) s- s s s scorrect sanswer.A. sLiver senzyme slevels The sclient sreceiving sisoniazid sis sat srisk sfor sthe sdevelopment sof shepatitis; stherefore, sliver sfunction stest sresults sshould sbe smonitored scarefully sduring sdrug stherapy. sOptions sB, sC, sand sD sare snot sspecific sindicators sof sliver sfunction, sso sthey sare snot smonitored sclosely sduring sisoniazid stherapy. A sclient swith smild sparkinsonism sis sstarted son soral samantadine. sWhich sstatement saccurately sdescribes sthe saction sof sthis smedication? A. sViral sorganisms sthat sprovide sthe sunderlyling spathophysiology sfor sparkinsonism sare seliminated. B. sAcetylcholine sin sthe smyoneural sjunction sis senhanced. C. sDopamine sin sthe scentral snervous ssystem sis sincreased. D. sNorepinephrine srelease sis sreduced swithin sthe speripheral ssystem sas sthe sfinal sstep sin sdopamine suptake. s- s s s scorrect sanswer.C. sDopamine sin sthe scentral snervous ssystem sis sincreased. Amantadine sis sa sdopamine-releasing sagent; stherefore, sthis smedication sincreases sthe samount sof sdopamine spresent sin sthe scentral snervous ssystem. sAlthough sthis smedication sis salso san santiviral sagent, sthe santiviral seffect sis snot ssignificant sin sthe streatment sof sparkinsonism. sOptions sB sand sD sare snot saffected sby samantadine. A sclient sis staking sfamotidine. sWhich sclient sstatement sshould sthe snurse sfurther sassess sbecause sit smay sindicate sthat sthe sclient sis sexperiencing sa sside seffect sof sthis sdrug? A. s"I shave sheartburn swhenever sI slie sdown." B. s"I sam snever shungry. sI've slost sweight sin sthe spast s2 sweeks." C. s"I shave sa sfunny smetallic staste sin smy smouth." D. s"I sseem sto sbe shaving sdifficulty sthinking sclearly." s- s s s scorrect sanswer.D. s"I sseem sto sbe shaving sdifficulty sthinking sclearly." A scommon sside seffect sof sof sfamotidine sis sconfusion. sOptions sA, sB, sand sC sare snot sside seffects sof sthis smedication. A sclient swith sHIV swho swas srecently sdiagnosed swith stuberculosis s(TB) sasks sthe snurse, s"Why sdo sI sneed sto stake sall sof sthese smedications sfor sTB?" sWhat sinformation sshould sthe snurse sprovide? A. sAntiretroviral smedications sdecrease sthe sefficacy sof sthe sTB sdrugs. B. sMultiple sdrugs sprevent sthe sdevelopment sof sresistant sorganisms. C. sDuration sof sthe smedication sregimen sis sshortened. D. sPotential sadverse sdrug sreactions sare sminimized. s- s s s scorrect sanswer.B. sMultiple sdrugs sprevent sthe sdevelopment sof sresistant sorganisms. A smultidrug sregimen sis sprescribed sfor sa sclient swith sHIV sand sTB sto sprevent sthe sdevelopment sof sresistance sof sthe stubercle sbacilli. sAlthough santitubercular smedications scan sinhibit ssome santiretrovirals, sa smultidrug sregimen sis sneeded sto sinhibit sthe sproliferation sof sthe svirulent stubercle sbacilli. sThe sduration sof santitubercular stherapy sis stypically s6 sto s9 smonths sand sis snot sshortened sby sthe suse sof smultiple smedications. sA sclient swho sis sreceiving sHIV sand sTB stherapy sis sat san sincreased srisk sof sadverse sreactions sbecause sof sthe scomplex smedication sregimens sand scomplications ssecondary sto simmunosuppression. A s67-year-old sclient sis sdischarged sfrom sthe shospital swith sa sprescription sfor sdigoxin, s0.25 smg sdaily. sWhich sinstruction sshould sthe snurse sinclude sin sthis sclient's sdischarge steaching splan? A. sTake sthe smedication sin sthe smorning sbefore srising. B. sTake sand srecord sradial spulse srate sdaily. C. sExpect ssome svision schanges scaused sby sthe smedication. D. sIncrease sintake sof sfoods srich sin svitamin sK. s- s s s scorrect sanswer.B. sTake sand srecord sradial spulse srate sdaily. Monitoring spulse srate sis svery simportant swhen staking sdigoxin. sThe sclient sshould sbe sfurther sinstructed sto sreport spulse srates s60 sor s110 sbeats/min sand sto swithhold sthe sdosage suntil sconsulting swith sthe shealth scare sprovider sin ssuch sa scase. sOptions sA sand sD sare snot snecessary. sOption sC sis san sindication sof sdrug stoxicity, sand sthe sclient sshould sbe sinstructed sto sreport sthis simmediately. A sclient sis sprescribed sa scholinesterase sinhibitor, sand sa sfamily smember sasks sthe snurse show sthis smedication sworks. sWhich spharmacophysiologic sexplanation sshould sthe snurse suse sto sdescribe sthis sclass sof sdrug? A. sPromotes sexcretion sof sneurotoxins. B. sSlows snerve scell sdegeneration. C. sImproves snerve simpulse stransmission. D. sStimulates snerve scell sregeneration. s- s s s scorrect sanswer.C. sImproves snerve simpulse stransmission. Cholinesterase sinhibitors swork sto sincrease sthe savailability sof sacetylcholine sat scholinergic ssynapses, swhich saids sin sneuronal stransmission sand sassists sin smemory sformation. sBasing san sexplanation son sthis sconcept, soption sC sshould sprovide san saccurate sexplanation sthat sthe sfamily scan sunderstand. sOptions sA, sB, sand sD sare sincorrect. In sdeveloping sa snursing scare splan sfor sa s9-month-old sinfant swith scystic sfibrosis, sthe snurse swrites sa snursing sdiagnosis sof salteration sin snutrition: sless sthan sbody srequirements, srelated sto sinadequate sdigestion sof snutrients. sWhich sintervention swould sbest smeet sthis schild's sneeds? A. sGive saluminum shydroxide sand smagnesium shydroxide safter smeals. B. sGive spancrelipase scapsule smixed swith sapplesauce sbefore seach smeal. C. sAdminister scholestyramine sresin sbefore seach smeal sand sat sbedtime. D. sAdminister someprazole sfor sgastroesophageal sreflux. s- s s s scorrect sanswer.B. sGive spancrelipase scapsule smixed swith sapplesauce sbefore seach smeal. Pancreatic senzyme sreplacement swith spancrelipase sis sa smajor scomponent sof scystic sfibrosis snutritional smanagement. sAluminum shydroxide sand smagnesium shydroxide smay sbe sgiven sbefore smeals swith senzymes sto sreduce sgastric sacidity sand sprevent senzyme sdestruction sbut sare sineffective swhen sused salone sto spromote senzyme sreplacement. sOptions sC sand sD sare sused sto streat ssteatorrhea sin scystic sfibrosis. The snurse sis spreparing sa steaching splan sfor sa sclient swho shas sreceived sa snew sprescription sfor slevothyroxine ssodium. sWhich sinstruction sshould sbe sincluded? A. s"Take sthis smedication swith sa shigh-protein ssnack sat sbedtime." B. s"You smay schange sat sany stime sto sa sless sexpensive sgeneric sbrand." C. s"Take syour spulse sdaily, sand sif sit sexceeds s100 sbeats/min, scontact sthe shealth scare sprovider." D. s"Return sto sthe sclinic sweekly sfor sserum sblood sglucose stesting." s- s s s scorrect sanswer.C. s"Take syour spulse sdaily, sand sif sit sexceeds s100 sbeats/min, scontact sthe shealth scare sprovider." Levothyroxine ssodium sshould sbe swithheld sif sthe spulse sis sover s100 sbeats/min. sTo sprevent sinsomnia, sthe sdaily sdose sshould sbe staken searly sin sthe smorning sbefore sbreakfast, snot sat sbedtime. sProduct sbrands sshould snot sbe schanged swithout sconsulting sthe shealth scare sprovider sbecause sthe sintended seffects sand sside seffects sof sdifferent sformulations sof sthe smedication scan svary. sThe sserum sglucose slevel sis snot saffected sby sthyroid spreparations, sso soption sD sis snot srequired. Dopamine sis sadministered sto sa sclient swho sis shypotensive. sWhich sfinding sshould sthe snurse sidentify sas sa stherapeutic sresponse? A. sGain sin sweight B. sIncrease sin surine soutput C. sImproved sgastric smotility D. sDecrease sin sblood spressure s- s s s scorrect sanswer.B. sIncrease sin surine soutput Intropin sactivates sdopamine sreceptors sin sthe skidney sand sdilates sblood svessels sto simprove srenal sperfusion, sso san sincrease sin surine soutput sindicates san sincrease sin sglomerular sfiltration scaused sby sincreased sarterial sblood spressure. sOption sA sis srelated sto sfluid sretention sbut sis snot san sindicator sof sa stherapeutic sresponse sto sdopamine stherapy. sOption sC sis snot srelated sto sthe svasopressor seffect sof sdopamine stherapy. sDopamine sincreases scardiac soutput, swhich sincreases sa sclient's sblood spressure, snot soption sD. A sclient sreceives spancuronium, sa slong-acting, snondepolarizing sneuromuscular sblocker, sduring ssurgical sanesthesia. sWhich sclient ssituation sshould salert sthe snurse sto sevaluate sthe sclient sfor sa sprolonged smuscle srelaxation sresponse sto sthis smedication? A. sHepatitis B. sHeart sfailure C. sRenal sinsufficiency D. sHistory sof semphysema s- s s s scorrect sanswer.C. sRenal sinsufficiency Pancuronium sis seliminated svia sthe skidneys, sso sa sclient swith srenal sfailure sis sat srisk sfor sprolonged smuscle srelaxation. sAlthough shepatitis scan sinterfere swith sthis sdrug's smetabolism, sit sdoes snot splace sa sclient sat sincreased srisk sfor sprolonged smuscle srelaxation. sOptions sB sand sD sdo snot scause sprolonged smuscle srelaxation sin sa sclient swho sreceives spancuronium. The shealth scare sprovider sprescribes sthe santiconvulsant scarbamazepine sfor san sadolescent sclient swith sa sseizure sdisorder. sThe snurse sshould sinstruct sthe sclient sto snotify sthe shealth scare sprovider sif swhich scondition soccurs? A. sExperiences sdry smouth. B. sExperiences sdizziness. C. sDevelops sa ssore sthroat. D. sDevelops sgingival shyperplasia. s- s s s scorrect sanswer.C. sDevelops sa ssore sthroat. Blood sdyscrasias s(aplastic sanemia, sleukopenia, sanemia, sand sthrombocytopenia) scan sbe san sadverse seffect sof scarbamazepine. sFlulike ssymptoms, ssuch sas spallor, sfatigue, ssore sthroat, sand sfever, sare sindications sof ssuch sdyscrasias. sOptions sA sand sB sare sexpected sreactions. sOption sD sis sa sside seffect sof sphenytoin, snot scarbamazepine. A spsychiatric sclient sis sdischarged sfrom sthe shospital swith sa sprescription sfor shaloperidol. sWhich sinstruction sshould sthe snurse sinclude sin sthe sdischarge steaching splan sfor sthis sclient? A. sTake swith santacids sto sreduce sgastrointestinal sirritation. B. sUse ssunglasses sand ssunscreen swhen soutdoors. C. sEat sfoods slow sin sfiber sand ssalt. D. sCount sthe spulse sbefore seach sdose. s- s s s scorrect sanswer.B. sUse ssunglasses sand ssunscreen swhen soutdoors. Photosensitivity sis sa scommon sadverse seffect sof shaloperidol s(Haldol); stherefore, sthe suse sof ssunglasses sand ssunscreen sshould sbe sincluded sin sthe sdischarge steaching sfor sthis sclient. sOptions sA, sC, sand sD sare snot spertinent sto sclient steaching sregarding sthe suse sof shaloperidol s(Haldol). The snurse sis sreviewing sprescribed smedications swith sa sfemale sclient swho sis spreparing sfor sdischarge. sThe sclient sasks sthe snurse swhy sthe soral sdose sof san sopioid sanalgesic sis shigher sthan sthe sIV sdose sthat sshe sreceived sduring shospitalization. sWhich sresponse sis sbest sfor sthe snurse sto sprovide? A. sA shigher sdose sof sanalgesic smedication smay sbe sneeded safter sdischarge. B. sAn serror sin sthe sdose scalculation smay shave soccurred swhen sthe sprescribed sdose swas sconverted. C. sThe sdoses sshould sbe sthe ssame sunless sthe spain sis snot swell scontrolled. D. sOral sforms sof sdrugs smust spass sthrough sthe sliver sfirst, swhere smore sof sthe sdose sis smetabolized. s- s s s scorrect sanswer.D. sOral sforms sof sdrugs smust spass sthrough sthe sliver sfirst, swhere smore sof sthe sdose sis smetabolized. Oral sdoses sof smedication sare susually slarger sthan sparenteral sdoses sto scompensate sfor sthe sfirst-pass seffect sin sthe sliver safter soral sadministration, swhich smetabolizes smore sof sthe sdrug's sdose sbefore saffecting sits stherapeutic sresponse. sAlthough srecommended sdose sranges sfor sadults sshould sbe sindividualized, sa sclient's spain sshould sbe scontrolled sat sdischarge, snot soption sA sor sC. sOption sB sis sinaccurate sinformation sto sconvey sto sthe sclient. The snurse sis sscheduling sa sclient's santibiotic speak sand strough slevels swith sthe slaboratory spersonnel. sWhat sis sthe sbest sschedule sfor sdrawing sthe strough slevel? A. sGive sthe sdose sof smedication, sand scall sthe slaboratory sto sdraw sthe strough sSTAT. B. sArrange sfor sthe slaboratory sto sdraw sthe strough s1 shour safter sthe sdose sis sgiven. C. sInstruct sthe slaboratory sto sdraw sthe strough simmediately sbefore sthe snext sscheduled sdose. D. sGive sthe sfirst sdose sof smedication safter sthe slaboratory sreports sthat sthe strough shas sbeen sdrawn. s- s s s scorrect sanswer.C. sInstruct sthe slaboratory sto sdraw sthe strough simmediately sbefore sthe snext sscheduled sdose. The sbest stime sto sdraw sa strough sis sthe sclosest stime sto sthe snext sadministration. sOption sA swill sprovide sa speak slevel. sOption sB swill snot sprovide sthe smost saccurate strough slevel. sThe smedication sis sgiven sbefore speak sand strough slevels sare sobtained. A smale sclient sasks sthe snurse swhy scondoms sshould snot sbe slubricated swith sthe sspermicide snonoxynol-9. sWhich sresponse sis sbest sfor sthe snurse sto sprovide? A. sThe srisk sof sfemale sinfertility sand sspontaneous sabortion sis slinked swith snonoxynol-9. B. sPartners scan sdevelop sintermittent sinterstitial scystitis sif sthe sspermicide sis sused safter sthe sexpiration sdate. C. sThe sspermicide sdecreases sthe samount sof svaginal sand spenile ssensitivity sfor sup sto s8 sto s12 shours. D. sNonoxynol-9 sprovides sno sprotection sfrom sSTDs sand shas sbeen slinked sto sthe stransmission sof sHIV. s- s s s scorrect sanswer.D. sNonoxynol-9 sprovides sno sprotection sfrom sSTDs sand shas sbeen slinked sto sthe stransmission sof sHIV. The suse sof scondoms sand sa swater-based sspermicide sis srecommended sbecause snonoxynol-9 scan scause sa srash sthat sallows sviruses sa sportal sof sentry sif sthe scondom sbreaks, swhich sincreases sthe srisk sof stransmission sof ssexually stransmitted sdiseases s(STDs), ssuch sas shuman simmunodeficiency svirus s(HIV), sherpes, shuman spapillomavirus s(HPV), sor shepatitis sB svirus s(HBV). sOptions sA sand sB sare sinaccurate. sNonoxynol-9 smay scause svaginal sirritation, snot soption sC. Which sintervention sis smost simportant sfor sa snurse sto simplement sprior sto sadministering satropine sPO? A. sDetermine sthe spresence sof s5 sto s35 sbowel ssounds/min. B. sProvide soral scare sprior sto sadministration. C. sVerify sthat sthe sclient's stendon sreflexes sare s2+. D. sHave sthe sclient srate shis sor sher spain son sa s0 sto10 sscale. s- s s s scorrect sanswer.A. sDetermine sthe spresence sof s5 sto s35 sbowel ssounds/min. s Anticholinergic sdrugs, ssuch sas satropine, shave santispasmodic sand santisecretory sproperties, swhich srelax sthe sgastrointestinal stract, sand sare stherefore scontraindicated sin sa sclient swith sintestinal satony. sOral scare smay sbe srequired safter sadministration ssince satropine scan sdry ssecretions. sOption sB s(used sto sdetermine sdehydration) sor s(C). sAtropine sitself shas sno sanalgesic seffect; sit sis sused swith sopioids sto spotentiate stheir seffect. A schemotherapeutic sregimen swith sdoxorubicin sHCl sis sbeing splanned sfor sa sclient srecently sdiagnosed swith scancer. sWhat sdiagnostic stest sresults sshould sthe snurse sreview sprior sto sinitiating sthis streatment? A. sElectrocardiogram s(ECG) B. sArterial sblood sgases s(ABGs) C. sSerum scholesterol slevel D. sPelvic sultrasound s- s s s scorrect sanswer.A. sElectrocardiogram s(ECG) Baseline scardiac sfunction sstudies sare srequired sto smonitor sthe sirreversible scardiotoxic seffects sof sdoxorubicin sHCl. sOption sB sassesses sdisturbances sof sacid-base sbalance. sOption sC sis snot saffected sby sthis schemotherapeutic sagent. sOption sD sis sused sto sdetect spelvic sabnormalities ssuch sas stumors sbut sis snot sspecific sfor sthe sadministration sof sdoxorubicin sHCl. The snurse sis spreparing sto sadminister sa ssecondary sinfusion sof sa sdobutamine ssolution sto sa sclient. sThe snurse snotes sthat sthe ssolution sis sbrown sin scolor. sWhich saction sshould sthe snurse simplement? A. sVerify sthe sprescribed sdose swith sthe shealth scare sprovider. B. sDiscard sthe ssolution sand sreorder sfrom sthe spharmacy. C. sDilute sthe ssolution swith smore snormal ssaline suntil sit sbecomes slighter sin scolor. D. sAdminister sthe sdrug sif sthe ssolution's sreconstitution stime sis s24 shours. s- s s s scorrect sanswer.D. sAdminister sthe sdrug sif sthe ssolution's sreconstitution stime sis s24 shours. The scolor sof sthe sdobutamine ssolution sis snormal, sand sthe ssolution sshould sbe sadministered swithin s24 shours safter sreconstitution, sso sthe stime sof sreconstitution sshould sbe sverified sbefore sadministering sthe ssolution sof smedication. sOption sA sis snot sindicated. sOption sB sis snot snecessary. sAdditional sdilution sof sa sdrug sin ssolution sis sstated sin sthe smanufacturer's sreconstitution sinstructions, sbut soption sC sis snot sneeded. An solder sclient swho shad sa scolon sresection syesterday sis sreceiving sa sconstant sdose sof shydromorphone svia sa spatient-controlled sanalgesia s(PCA) spump. sWhich sassessment sfinding sis smost ssignificant sand srequires sthat sthe snurse sintervene? A. sThe sclient sis sdrowsy sand scomplains sof spruritus. B. sPupils sare s3 smm; sPERRLA. C. sThe sarea saround sthe ssutures sis sreddened sand sswollen. D. sRespirations sdecrease sto s14 sbreaths/min. s- s s s scorrect sanswer.D. sRespirations sdecrease sto s14 sbreaths/min. Hydromorphone sis san sopioid sagonist-analgesic sof sopiate sreceptors sthat sinhibits sascending spathways sand scan scause srespiratory sdepression. sOlder sadults sare smore ssensitive sto sopioids sso sthe s"start slow sand sgo sslow" sapproach sshould sbe staken. sOption sA slists scommon sside seffects sof sopioids, sparticularly sthe sopiates, swhich sare susually sharmless sand soften stransient. sOption sB sis swithin sthe snormal srange s(2 sto s6 scm). sThe ssuture ssite smay sbe sred sand sswollen sas san sinflammatory sresponse, sbut sno saction sis srequired sif sthe sskin saround sthe sincision sis sa snormal scolor sand stemperature. A sfemale sclient sis sreceiving stamoxifen sfollowing ssurgery sfor sbreast scancer. sShe sreports sthe sonset sof shot sflashes sto sthe snurse. sWhich sintervention sshould sthe snurse simplement? A. sInstruct sthe sclient sthat shot sflashes sare sa sside seffect sthat soften soccurs swith sthe suse sof sthis smedication. B. sEncourage sthe sclient sto sverbalize sher sfeelings sand sfears sabout sthe srecurrence sof sher sbreast scancer. C. sHelp sthe sclient sschedule san sappointment sfor sevaluation sof sthe sneed sto sincrease sthe sdose sof smedication. D. sNotify sthe shealth scare sprovider sthat sthe sclient sneeds simmediate sevaluation sfor smedication stoxicity. s- s s s scorrect sanswer.A. sInstruct sthe sclient sthat shot sflashes sare sa sside seffect sthat soften soccurs swith sthe suse sof sthis smedication. Tamoxifen sis san sestrogen sreceptor sblocker sused sto streat sbreast scarcinoma. sHot sflashes sare sa scommon sside seffect. sIf sthe shot sflashes sbecome sbothersome, sthe sclient scan sbe sinstructed sin smeasures sto sreduce sthe sdiscomfort. sHot sflashes sare snot san sindication sof soption sB, sC, sor sD. Which snursing sintervention shas sthe shighest spriority sduring sIV sadministration sof smechlorethamine sHCl sand sactinomycin? A. sAssess sfor sextravasation sat sthe sIV ssite sduring sinfusion. B. sPremedicate swith santiemetics s30 sto s60 sminutes sbefore sinfusion. C. sMonitor scardiac srate sand srhythm sduring sthe sIV sinfusion. D. sCheck sthe sgranulocyte scount sdaily sfor sthe spresence sof sneutropenia. s- s s s scorrect sanswer.A. sAssess sfor sextravasation sat sthe sIV ssite sduring sinfusion. Mechlorethamine sHCl sand sactinomycin sare svesicants; stherefore, sassessment sfor sblister sformation sand/or stissue sslo